- Home
- JNPR vs NBIX Comparison
JNPR vs NBIX Comparison
Compare JNPR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNPR
- NBIX
- Stock Information
- Founded
- JNPR 1996
- NBIX 1992
- Country
- JNPR United States
- NBIX United States
- Employees
- JNPR N/A
- NBIX N/A
- Industry
- JNPR Computer Communications Equipment
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JNPR Telecommunications
- NBIX Health Care
- Exchange
- JNPR Nasdaq
- NBIX Nasdaq
- Market Cap
- JNPR 11.6B
- NBIX 11.0B
- IPO Year
- JNPR 1999
- NBIX 1996
- Fundamental
- Price
- JNPR $34.33
- NBIX $101.38
- Analyst Decision
- JNPR Buy
- NBIX Strong Buy
- Analyst Count
- JNPR 6
- NBIX 21
- Target Price
- JNPR $39.80
- NBIX $163.00
- AVG Volume (30 Days)
- JNPR 2.8M
- NBIX 1.8M
- Earning Date
- JNPR 05-01-2025
- NBIX 05-05-2025
- Dividend Yield
- JNPR 2.54%
- NBIX N/A
- EPS Growth
- JNPR N/A
- NBIX 33.20
- EPS
- JNPR 0.86
- NBIX 3.29
- Revenue
- JNPR $5,073,600,000.00
- NBIX $2,355,300,000.00
- Revenue This Year
- JNPR $9.31
- NBIX $15.48
- Revenue Next Year
- JNPR $3.97
- NBIX $15.99
- P/E Ratio
- JNPR $39.92
- NBIX $30.81
- Revenue Growth
- JNPR N/A
- NBIX 24.81
- 52 Week Low
- JNPR $33.42
- NBIX $84.23
- 52 Week High
- JNPR $39.79
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- JNPR 37.19
- NBIX 46.65
- Support Level
- JNPR $34.23
- NBIX $84.23
- Resistance Level
- JNPR $35.21
- NBIX $112.74
- Average True Range (ATR)
- JNPR 0.80
- NBIX 5.17
- MACD
- JNPR -0.06
- NBIX 0.59
- Stochastic Oscillator
- JNPR 32.38
- NBIX 60.45
About JNPR Juniper Networks Inc.
Juniper Networks Inc is engaged in designing, developing, and selling products and services for high-performance networks to enable customers to build scalable, reliable, secure, and cost-effective networks for their businesses while achieving agility and improved operating efficiency through automation. The company's high-performance network and service offerings include routing, switching, Wi-Fi, network security, artificial intelligence (AI) or AI-enabled enterprise networking operations (AIOps), and software-defined networking (SDN) technologies. In addition to the company's products, the company offers its customers a variety of services, including maintenance and support, professional services, Software-as-a-Service (SaaS), and education and training programs.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.